Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma × arexvy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Cyclophosphamide 27 fludarabine 18 Rituximab 16 obinutuzumab 11 venetoclax 9 Lenalidomide 9 Bendamustine Hydrochloride 9 Prednisone 7 zanubrutinib 5 pembrolizumab 5 ibrutinib 5 Exercise 5 Etoposide 5 Doxorubicin 5 Blood Specimen Collection 5 Biopsy 5 fludarabine phosphate 4 Vincristine 4 Mesna 4 Cytarabine 4 tafasitamab 3 loncastuximab tesirine 3 glofitamab 3 axicabtagene ciloleucel 3 acalabrutinib 3 Trimethoprim, Sulfamethoxazole Drug Combination 3 Temozolomide 3 Surveys and Questionnaires 3 Radiotherapy 3 Palliative Care 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡